Difficulty: Medium
Average Score: 77%
Practice
The mechanism of high - level INH resistance of M tuberculosis is
Correct answer
B
Rationale
The correct answer to the question about the mechanism of high-level INH resistance of M. tuberculosis is option B: Reduced expression of the katG gene. This is because INH (Isoniazid) is a prodrug that requires activation by the enzyme catalase-peroxidase encoded by the katG gene in M. tuberculosis. Reduced expression of the katG gene leads to insufficient activation of INH, resulting in the bacterium being resistant to the drug.
Option A, the formation of drug-inactivating N-acetyltransferase, is incorrect because this mechanism is associated with resistance to another anti-tuberculosis drug, streptomycin, not INH.
Option C, decreased intracellular accumulation of NH, is also incorrect as it does not directly relate to the mechanism of high-level INH resistance in M. tuberculosis.
Option D, mutation in the inhA gene, is incorrect as well because mutations in the inhA gene are associated with resistance to another anti-tuberculosis drug, ethionamide, not INH.
In an educational context, understanding the mechanisms of drug resistance in tuberculosis is crucial for healthcare professionals involved in the treatment of patients with TB. Proper knowledge of these mechanisms helps in selecting the most effective drug regimens, preventing the development of resistance, and improving patient outcomes. It also underscores the importance of appropriate diagnostics and monitoring to detect and address resistance early.
Option A, the formation of drug-inactivating N-acetyltransferase, is incorrect because this mechanism is associated with resistance to another anti-tuberculosis drug, streptomycin, not INH.
Option C, decreased intracellular accumulation of NH, is also incorrect as it does not directly relate to the mechanism of high-level INH resistance in M. tuberculosis.
Option D, mutation in the inhA gene, is incorrect as well because mutations in the inhA gene are associated with resistance to another anti-tuberculosis drug, ethionamide, not INH.
In an educational context, understanding the mechanisms of drug resistance in tuberculosis is crucial for healthcare professionals involved in the treatment of patients with TB. Proper knowledge of these mechanisms helps in selecting the most effective drug regimens, preventing the development of resistance, and improving patient outcomes. It also underscores the importance of appropriate diagnostics and monitoring to detect and address resistance early.